Asset Dedication’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$109K Sell
568
-275
-33% -$29.6K 0.01% 387
2026
Q2
$59K Hold
843
– – ﹤0.01% 475
2026
Q1
$42.8K Hold
843
– – ﹤0.01% 497
2025
Q4
$24.9K Hold
843
– – ﹤0.01% 625
2025
Q3
$21.8K Sell
843
-2
-0.2% -$56 ﹤0.01% 662
2025
Q2
$23.3K Sell
845
-268
-24% -$7.06K ﹤0.01% 663
2025
Q1
$31.6K Buy
1,113
+163
+17% +$5.78K ﹤0.01% 558
2024
Q4
$39.5K Sell
950
-68
-7% -$3.25K ﹤0.01% 517
2024
Q3
$68K Hold
1,018
– – ﹤0.01% 461
2024
Q2
$121K Buy
1,018
+300
+42% +$38K 0.01% 380
2024
Q1
$76K Sell
718
-50
-7% -$5.04K 0.01% 396
2023
Q4
$77K Hold
768
– – 0.01% 382
2023
Q3
$79K Buy
768
+50
+7% +$5.58K 0.01% 386
2023
Q2
$87K Hold
718
– – 0.01% 384
2023
Q1
$110K Hold
718
– – 0.01% 353
2022
Q4
$129K Hold
718
– – 0.01% 341
2022
Q3
$85K Hold
718
– – 0.01% 357
2022
Q2
$103K Sell
718
-40
-5% -$5.72K 0.02% 189
2022
Q1
$131K Hold
758
– – 0.01% 333
2021
Q4
$192K Sell
758
-2
-0.3% -$585 0.02% 281
2021
Q3
$292K Buy
760
+42
+6% +$15.5K 0.04% 230
2021
Q2
$169K Buy
718
+650
+956% +$116K 0.03% 277
2021
Q1
$9K Sell
68
-77
-53% -$11.2K ﹤0.01% 516
2020
Q4
$15K Buy
145
+77
+113% +$7.79K ﹤0.01% 498
2020
Q3
$5K Hold
68
– – ﹤0.01% 600
2020
Q2
$4K Buy
+68
New +$3.72K ﹤0.01% 549

Other funds holding MRNA

Asset Dedication's MRNA Position: Q3 2026 in Review

Asset Dedication reduced its Moderna (MRNA) stake by 33% in Q3 2026, selling an estimated $29.6K and leaving 568 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #387.

Asset Dedication first reported a position in MRNA in Q2 2020 and has held it in 26 quarters since. The position peaked at $292K in Q3 2021. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Asset Dedication held 568 shares of Moderna worth $109K as of Q3 2026.
  • Asset Dedication sold 275 Moderna shares in Q3 2026, an estimated $29.6K.
  • Moderna made up 0.01% of Asset Dedication's portfolio in Q3 2026, its #387 holding.
  • Asset Dedication first reported a position in Moderna in Q2 2020 and has held it in 26 quarters since.
  • Asset Dedication's Moderna position peaked at $292K in Q3 2021.
  • 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.